Treatment of Stage I and II Non-small Cell Lung Cancer

2013/05/01 by John A. Howington, Matthew G. Blum, Andrew C. Chang +3 · 26 citations
Medicine · #Lung Cancer Diagnosis and Treatment #Lung Cancer Research Studies #Radiomics and Machine Learning in Medical Imaging

paper · doi:10.1378/chest.12-2359

Cited by

• Clinical implications of positive margins following non‐small cell lung cancer surgery
• The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. [europepmc]
• A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. [europepmc]
• LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective. [europepmc]
• Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study. [europepmc]
• Lung cancer: Biology and treatment options. [europepmc]
• Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base. [europepmc]
• The Utility of Exercise Testing in Patients with Lung Cancer. [europepmc]
• Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC. [europepmc]
• Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial. [europepmc]
• Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival. [europepmc]
• Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer. [europepmc]
• Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery. [europepmc]
• Nationwide Assessment of Robotic Lobectomy for Non-Small Cell Lung Cancer. [europepmc]
• Risk factors and short-term outcomes of postoperative pulmonary complications after VATS lobectomy. [europepmc]
• Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks. [europepmc]
• A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers. [europepmc]
• Effects of probiotics on chemotherapy in patients with lung cancer. [europepmc]
• Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer. [europepmc]
• Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. [europepmc]
• Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing. [europepmc]
• Perspectives and controversies regarding the use of natural products for the treatment of lung cancer. [europepmc]
• Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time? [europepmc]
• Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. [europepmc]
• Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study: An Analysis of 5721 Cases. [europepmc]
• Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer. [europepmc]